$MDVN Announces Participation at Upcoming Investor Conference


Medivation Announces Participation at Upcoming Investor Conference

SAN FRANCISCO, CA–(Marketwired – May 4, 2015) – Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conference:

  • David Hung, M.D., president and chief executive officer and Rick Bierly, chief financial officer will participate in a fireside chat at the UBS Global Healthcare Conference on Monday, May 18, at 1:30pm ET at the Sheraton Times Square Hotel in New York, NY

Individuals may access the live audio webcast by visiting:http://investors.medivation.com/events.cfm. A replay of the webcast will be available on the Company’s website for 30 days following the live event.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the development and commercialization of medically innovative therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us athttp://www.medivation.com


Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900


Please enter your comment!
Please enter your name here